Cargando…

High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study

We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesve...

Descripción completa

Detalles Bibliográficos
Autores principales: Goss, Franz, Brachmann, Johannes, Hamm, Christian W, Haerer, Winfried, Reifart, Nicolaus, Levenson, Benny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388240/
https://www.ncbi.nlm.nih.gov/pubmed/28435280
http://dx.doi.org/10.2147/VHRM.S119490
_version_ 1782521095808614400
author Goss, Franz
Brachmann, Johannes
Hamm, Christian W
Haerer, Winfried
Reifart, Nicolaus
Levenson, Benny
author_facet Goss, Franz
Brachmann, Johannes
Hamm, Christian W
Haerer, Winfried
Reifart, Nicolaus
Levenson, Benny
author_sort Goss, Franz
collection PubMed
description We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesverband Niedergelassener Kardiologen [German Federation of Office-Based Cardiologists] cardiac pass with visit scheduling) shared by the hospital physician and the office-based cardiologist, the definition of individual treatment targets, and the systematic information of patients in order to optimize adherence to therapy. Participating centers (36 hospitals, 60 office-based cardiologists) included a total of 1,003 patients with ACS (ST-segment elevation myocardial infarction [STEMI] 44.3%, non-ST-segment elevation myocardial infarction [NSTEMI] 39.5%, unstable angina pectoris [UA] 15.2%, and unspecified 1.0%). During follow-up, treatment rates with cardiac medication remained high in all groups, with dual antiplatelet therapy in 91.0% at 3 months, 90.0% at 6 months, and 82.8% at 12 months, respectively. Twelve months after the inclusion, a total of 798 patients (79.6%) still participated in the program. Eighteen patients (1.8%) had died after discharge from hospital (6 in the STEMI, 12 in the NSTEMI group), while for 58 the status was unknown (5.8%). Based on a conservative approach that considered patients with unknown status as dead, 1-year mortality was 7.6%. Recurrent cardiac events were noted in 14.9% at 1 year, with an about equal distribution across STEMI and NSTEMI patients. In conclusion, patients’ acceptance of the ProAcor program as determined by adherence rates over time was high. Treatment rates of recommended medications used for patients with coronary heart disease were excellent. The 1-year mortality rate was comparatively low.
format Online
Article
Text
id pubmed-5388240
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53882402017-04-21 High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study Goss, Franz Brachmann, Johannes Hamm, Christian W Haerer, Winfried Reifart, Nicolaus Levenson, Benny Vasc Health Risk Manag Original Research We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesverband Niedergelassener Kardiologen [German Federation of Office-Based Cardiologists] cardiac pass with visit scheduling) shared by the hospital physician and the office-based cardiologist, the definition of individual treatment targets, and the systematic information of patients in order to optimize adherence to therapy. Participating centers (36 hospitals, 60 office-based cardiologists) included a total of 1,003 patients with ACS (ST-segment elevation myocardial infarction [STEMI] 44.3%, non-ST-segment elevation myocardial infarction [NSTEMI] 39.5%, unstable angina pectoris [UA] 15.2%, and unspecified 1.0%). During follow-up, treatment rates with cardiac medication remained high in all groups, with dual antiplatelet therapy in 91.0% at 3 months, 90.0% at 6 months, and 82.8% at 12 months, respectively. Twelve months after the inclusion, a total of 798 patients (79.6%) still participated in the program. Eighteen patients (1.8%) had died after discharge from hospital (6 in the STEMI, 12 in the NSTEMI group), while for 58 the status was unknown (5.8%). Based on a conservative approach that considered patients with unknown status as dead, 1-year mortality was 7.6%. Recurrent cardiac events were noted in 14.9% at 1 year, with an about equal distribution across STEMI and NSTEMI patients. In conclusion, patients’ acceptance of the ProAcor program as determined by adherence rates over time was high. Treatment rates of recommended medications used for patients with coronary heart disease were excellent. The 1-year mortality rate was comparatively low. Dove Medical Press 2017-04-06 /pmc/articles/PMC5388240/ /pubmed/28435280 http://dx.doi.org/10.2147/VHRM.S119490 Text en © 2017 Goss et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Goss, Franz
Brachmann, Johannes
Hamm, Christian W
Haerer, Winfried
Reifart, Nicolaus
Levenson, Benny
High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
title High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
title_full High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
title_fullStr High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
title_full_unstemmed High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
title_short High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
title_sort high adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in germany: 1-year outcomes of the proacor study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388240/
https://www.ncbi.nlm.nih.gov/pubmed/28435280
http://dx.doi.org/10.2147/VHRM.S119490
work_keys_str_mv AT gossfranz highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy
AT brachmannjohannes highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy
AT hammchristianw highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy
AT haererwinfried highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy
AT reifartnicolaus highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy
AT levensonbenny highadherencetotherapyandlowcardiacmortalityandmorbidityinpatientsafteracutecoronarysyndromesystematicallymanagedbyofficebasedcardiologistsingermany1yearoutcomesoftheproacorstudy